ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos) (KRONOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02497001
Recruitment Status : Completed
First Posted : July 14, 2015
Last Update Posted : July 25, 2018
Sponsor:
Information provided by (Responsible Party):
Pearl Therapeutics, Inc.